Pathology Outlines - D2-40 (Podoplanin)
D2-40/p63 defined lymph vessel invasion has additional prognostic value in highly proliferating operable node negative breast cancer patients | Modern Pathology
Pathology Outlines - D2-40 (Podoplanin)
Pathology Outlines - D2-40 (Podoplanin)
Pathology Outlines - D2-40 (Podoplanin)
Pathology Outlines - D2-40 (Podoplanin)
Pathology Outlines - D2-40 (Podoplanin)
Monoclonal Antibody D2-40, a New Marker of Lymphatic Endothelium, Reacts with Kaposi's Sarcoma and a Subset of Angiosarcomas | Modern Pathology
Sensitivity and specificity of D2-40 in differentiating Kaposi sarcoma from its mimickers Genedy RM, Hamza AM, Abdel Latef AA, El-Beity AA - J Egypt Womens Dermatol Soc
D2-40 immunohistochemical overexpression in cutaneous squamous cell carcinomas: A marker of metastatic risk - ScienceDirect
Sensitivity and specificity of D2-40 in differentiating Kaposi sarcoma from its mimickers Genedy RM, Hamza AM, Abdel Latef AA, El-Beity AA - J Egypt Womens Dermatol Soc
Lymph vascular invasion in invasive mammary carcinomas identified by the endothelial lymphatic marker D2-40 is associated with other indicators of poor prognosis | BMC Cancer | Full Text
Cyclooxygenase-2–dependent lymphangiogenesis promotes nodal metastasis of postpartum breast cancer
Pathology Outlines - D2-40 (Podoplanin)
Lymph vascular invasion in invasive mammary carcinomas identified by the endothelial lymphatic marker D2-40 is associated with other indicators of poor prognosis | BMC Cancer | Full Text
Monoclonal Antibody D2-40, a New Marker of Lymphatic Endothelium, Reacts with Kaposi's Sarcoma and a Subset of Angiosarcomas | Modern Pathology
Sensitivity and specificity of D2-40 in differentiating Kaposi sarcoma from its mimickers Genedy RM, Hamza AM, Abdel Latef AA, El-Beity AA - J Egypt Womens Dermatol Soc
Sensitivity and specificity of D2-40 in differentiating Kaposi sarcoma from its mimickers Genedy RM, Hamza AM, Abdel Latef AA, El-Beity AA - J Egypt Womens Dermatol Soc
D2-40/p63 defined lymph vessel invasion has additional prognostic value in highly proliferating operable node negative breast cancer patients | Modern Pathology
Pathology Outlines - D2-40 (Podoplanin)
Pathology Outlines - D2-40 (Podoplanin)
Pathology Outlines - D2-40 (Podoplanin)
